Skip to content
Bending the Curve Trial by Trial
?

Co-author, with E. Grunberg, of the 1963 Experientia report on tumour-inhibiting methylhydrazine derivatives

W. Bollag

Listed in PubMed as first of two authors, with E. Grunberg, of the 1963 Experientia paper "Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives". PubMed gives only the initial of the forename.

Sources

  1. BOLLAG W, GRUNBERG E. Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives. Experientia. 1963;19:130-1.

    PubMedDOI